"10.1371_journal.pone.0070332","plos one","2013-07-31T00:00:00Z","Mariana Lopes dos Santos; Fernanda Perez Yeda; Lilian Rumi Tsuruta; Bruno Brasil Horta; Alécio A Pimenta; Theri Leica Degaki; Ibere C Soares; Maria Carolina Tuma; Oswaldo Keith Okamoto; Venancio A F Alves; Lloyd J Old; Gerd Ritter; Ana Maria Moro","Lab. de Biofármacos em Células Animais, Instituto Butantan, São Paulo, Brazil; Recepta Biopharma, São Paulo, Brazil; LIM14-Depto. de Patologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; Depto. de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil; Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, United States of America","Conceived and designed the experiments: AMM. Performed the experiments: MLS FPY LRT BBH AAP TLD ICS. Analyzed the data: AMM LRT BBH VAFA GR. Contributed reagents/materials/analysis tools: LJO OKO MCT. Wrote the paper: AMM MLS. Critical review of the manuscript: GR MCT OKO. Coordination of the study and funding: AMM.","MLS, FPY, LRT, BBH, AAPJr, TLD, ICS received fellowships from Recepta biopharma during the realization of this work. The grants were provided by Recepta biopharma through Government funding. MCT is employed by Recepta biopharma. VAFA and OKO acted as consultants for Recepta biopharma. AMM received a fellowship through Fundação Butantan. GR is listed as an inventor on a patent application (PCT/US200900576) on the “Membrane Transporter NaPi2b (SLC34A2)Epitope for Antibody Therapy, Antibodies directed thereto and Target for Cancer Therapy”. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Mariana Lopes dos Santos","MLDS",13,TRUE,1,7,5,2,TRUE,FALSE,FALSE,0,NA,FALSE
